{"id":"CHEMBL102358","canonicalSmiles":"O=C(/C=C/c1ccccc1)NCCO","inchiKey":"OSCTXCOERRNGLW-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDROCILAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idrocilamide"],"crossReferences":{"PubChem":["144205698","170466602","26757929"],"drugbank":["DB13297"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1081615","canonicalSmiles":"COc1[nH]c(=O)c(C(=O)[C@@H](C)C[C@H](C)[C@@H](Cl)CCl)c(O)c1OC","inchiKey":"OVULNOOPECCZRG-CIUDSAMLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATPENIN A5","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atpenin A5"],"crossReferences":{"drugbank":["DB04631"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1084617","canonicalSmiles":"COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1","inchiKey":"ZEOQUKRCASTCFR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMANOGREL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APD-791","APD791","Apd791","Temanogrel"],"childChemblIds":["CHEMBL2105696"],"count":1,"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0005672"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1198500","canonicalSmiles":"N[C@H](CC1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"JGFCNVHEEMBVJG-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198500","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07190"]},"childChemblIds":["CHEMBL606184"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200425","canonicalSmiles":"C#CCN(C)Cc1ccccc1.Cl","inchiKey":"BCXCABRDBBWWGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARGYLINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL673","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eutonyl"],"synonyms":["A-19120","MO-911","Pargyline hydrochloride"],"crossReferences":{"PubChem":["144203792","144212995","170465066","50106924","56422872","855526"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200495","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+]","inchiKey":"HHZQLQREDATOBM-CODXZCKSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE SODIUM SUCCINATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL977","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A-hydrocort","Hcss","Hydrocortisone sodium succinate","Solu-cortef"],"synonyms":["Hydrocortisone 21-sodium succinate","Hydrocortisone sodium succinate","NSC-9152","SOLU-CORTEF"],"crossReferences":{"DailyMed":["hydrocortisone%20sodium%20succinate"],"PubChem":["144207050","170465053","50106430","855547"],"chEBI":["5782"]},"count":10,"approvedIndications":["EFO_0000270","EFO_0009552","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0006834","EFO_0000220","EFO_0000403","MONDO_0000870","HP_0004798","EFO_0000565","EFO_0000309","EFO_0003032","EFO_0000270","EFO_1001936","EFO_1001947","EFO_0009552","MONDO_0020743","EFO_0005752"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL1200673","canonicalSmiles":"[127Xe]","inchiKey":"FHNFHKCVQCLJFQ-AHCXROLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XENON XE 127","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1236802","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xenon xe 127"],"synonyms":["127xe","Xenon (127Xe)","Xenon (127Xe) Gas","Xenon (127xe) gas","Xenon xe 127","Xenon xe-127"],"crossReferences":{"drugbank":["DB09461"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200710","canonicalSmiles":"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl","inchiKey":"WIMWMKZEIBHDTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOMIPRAMINE HYDROCHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL415","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anafranil","Anafranil sr","Chlorimipramine","Clomipramine hydrochloride","Tranquax"],"synonyms":["Clomipramine hydrochloride","G 34586","G-34586"],"crossReferences":{"DailyMed":["clomipramine%20hydrochloride"],"PubChem":["144212136","26747483","50106071","56422907","855785"],"chEBI":["3755"]},"count":1,"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200781","canonicalSmiles":"Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21","inchiKey":"WIHMBLDNRMIGDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CITALOPRAM HYDROBROMIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL549","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Celexa","Cipramil","Citalopram hydrobromide","Paxoran"],"synonyms":["Citalopram hydrobromide","LU 10-171-B","LU-10-171-B"],"crossReferences":{"DailyMed":["citalopram%20hydrobromide"],"PubChem":["26719710","29215151","46500388","50106010","50106011"]},"count":4,"approvedIndications":["MONDO_0002009","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0004262","MONDO_0002009","EFO_0003758","EFO_0003761","HP_0031217"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for major depressive disorder and unipolar depression and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200906","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1.[Br-]","inchiKey":"UKLQXHUGTKWPSR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENONIUM BROMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201286","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antrenyl"],"synonyms":["Oxyphenonium bromide"],"crossReferences":{"PubChem":["144204402","170465282","56422900","855750"],"Wikipedia":["Oxyphenonium_bromide"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200929","canonicalSmiles":"O=S(=O)([O-])[O-].[Zn+2]","inchiKey":"NWONKYPBYAMBJT-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC SULFATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pennine","Sootheye","White Vitriol","Z Span","Zinc sulfate","Zincfrin","Zincomed","Zincosol","Zindole","Zing","Zn sulf co"],"synonyms":["NSC-135806","NSC-32677","Zinc sulfate","Zinc sulfate monohydrate"],"crossReferences":{"DailyMed":["zinc%20sulfate"],"DrugCentral":["4275"],"Wikipedia":["Zinc_sulfate"],"drugbank":["DB09322"],"chEBI":["35176"]},"count":14,"approvedIndications":["EFO_0004272","EFO_0001070","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 3 approved and 11 investigational indications."}
{"id":"CHEMBL1200990","canonicalSmiles":"CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1.[Na+]","inchiKey":"AUAGTGKMTMVIKN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FLURBIPROFEN SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL563","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ansaid","Flurbiprofen Sodium","Occufen","Ocufen","Zepolas"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201027","canonicalSmiles":"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-]","inchiKey":"VPNYRYCIDCJBOM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOPYRROLATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201335","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cuvposa","Glycopyrrolate","Glyrx-pf","Lonhala magnair kit","Robinul","Robinul forte","Robinul fte","Seebri","Sialanar"],"synonyms":["AD-237","AHR-504","CHF-5259","CHF5259","Glycopyrrolate","Glycopyrrone bromide","Glycopyrronium bromide","NSC-250836","NSC-251251","NSC-251252","NVA-237","NVA237","ORG-NC-45","PT-001","PT001"],"crossReferences":{"DailyMed":["glycopyrrolate"],"PubChem":["144206695","144206696","170465427","85273808"]},"count":9,"approvedIndications":["HP_0006536","EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004210","EFO_0009512","EFO_0001645","EFO_0009516","MONDO_0001187","HP_0006536","MONDO_0002050","EFO_0010282","EFO_0000270","HP_0000975","EFO_0000341","HP_0002307","GO_0007596"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for gastrointestinal disease and airway obstruction and has 7 investigational indications."}
{"id":"CHEMBL1201032","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.O=C(O)c1ccccc1","inchiKey":"JPRXYLQNJJVCMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIZATRIPTAN BENZOATE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL905","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxalt","Maxalt-mlt","Rizatriptan benzoate"],"synonyms":["MK-0462","Rizatriptan benzoate"],"crossReferences":{"DailyMed":["rizatriptan%20benzoate"]},"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["EFO_0005296","EFO_0003821","EFO_0005295"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL1201061","canonicalSmiles":"CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.Cl","inchiKey":"OWNWYCOLFIFTLK-YDALLXLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVALBUTEROL HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1002","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levalbuterol hydrochloride","Xopenex"],"synonyms":["Albuterol (r)-form hydrochloride","Levalbuterol hydrochloride","Levosalbutamol hydrochloride"],"crossReferences":{"DailyMed":["levalbuterol%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0000270"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999 and is indicated for asthma."}
{"id":"CHEMBL1201219","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1","inchiKey":"BGSZAXLLHYERSY-XQIGCQGXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VECURONIUM","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vecuronium"],"crossReferences":{"DailyMed":["vecuronium%20bromide"],"PubChem":["50112721"],"Wikipedia":["Vecuronium_bromide"],"drugbank":["DB01339"],"chEBI":["9939"]},"childChemblIds":["CHEMBL1200629"],"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["MONDO_0018373","EFO_0004210","EFO_0002506","HP_0003040","EFO_0005323","MONDO_0043510","EFO_1001250","EFO_0004337"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201313","canonicalSmiles":"CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl","inchiKey":"WRCHFMBCVFFYEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOPHEDIANOL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlophedianol","Clofedanol"],"crossReferences":{"PubChem":["144206265","93577132"],"Wikipedia":["Clofedanol"],"drugbank":["DB04837"]},"childChemblIds":["CHEMBL1200972"],"count":1,"approvedIndications":["HP_0012735"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for cough."}
{"id":"CHEMBL1201342","canonicalSmiles":"CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1","inchiKey":"MJFJKKXQDNNUJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIXENE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methixene","Metixene"],"crossReferences":{"Wikipedia":["Metixene"],"drugbank":["DB00340"],"chEBI":["51024"]},"childChemblIds":["CHEMBL2359044","CHEMBL1200426"],"count":1,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000168539","ENSG00000147246"],"count":2},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for parkinson's disease."}
{"id":"CHEMBL1201505","drugType":"Unknown","blackBoxWarning":false,"name":"FIBRINOLYSIN, HUMAN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actase"],"synonyms":["Fibrinolysin","Fibrinolysin (human)","Fibrinolysin, human","Plasmin"],"crossReferences":{"Wikipedia":["Fibrinolysin"]},"count":1,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000171560","ENSG00000171564","ENSG00000171557"],"count":3},"linkedDiseases":{"rows":["HP_0002140","HP_0004419","MONDO_0020673"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1964 and is indicated for recurrent thrombophlebitis."}
{"id":"CHEMBL1201587","drugType":"Antibody","blackBoxWarning":true,"name":"ALEMTUZUMAB","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Campath","Campath Mabcampath, Lemtrada","Campath mabcampath","Lemtrada","Mabcampath"],"synonyms":["Alemtuzumab","Alemtuzumab (genetical recombination)","CAMPATH-1H","GZ-402673","GZ402673","LDP-03"],"crossReferences":{"DailyMed":["alemtuzumab"],"DrugCentral":["4909"],"Wikipedia":["Alemtuzumab"]},"count":63,"approvedIndications":["EFO_0003885","EFO_0000095","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000169442"],"count":1},"linkedDiseases":{"rows":["EFO_1001257","Orphanet_183660","EFO_0007323","Orphanet_848","EFO_0005952","EFO_0000540","EFO_0000565","EFO_0006803","EFO_0007160","EFO_0003884","MONDO_0015540","EFO_1000785","EFO_0000400","Orphanet_379","EFO_0000198","EFO_0009441","MONDO_0013730","EFO_0000220","EFO_0001642","MONDO_0008170","EFO_1001946","MONDO_0044881","EFO_0000384","MONDO_0009453","MONDO_0044889","MONDO_0001023","MONDO_0021193","EFO_0001359","MONDO_0019472","EFO_0002428","EFO_0000574","EFO_1001051","EFO_0001378","EFO_0003086","Orphanet_84","Orphanet_232","EFO_0000255","EFO_0000209","HP_0001915","EFO_1001264","MONDO_0003541","MONDO_0002087","EFO_1002048","MONDO_0002158","Orphanet_68364","EFO_1001996","EFO_0004289","EFO_0004272","EFO_0000183","EFO_0000616","EFO_0000685","EFO_0000403","EFO_0003929","EFO_0000222","MONDO_0000870","MONDO_0019469","EFO_0004599","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0003885","EFO_0000095","EFO_0001421","EFO_0006927","EFO_1001947","MONDO_0002367","EFO_1000560","Orphanet_2781","HP_0100727"],"count":69},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 60 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201637","drugType":"Enzyme","blackBoxWarning":false,"name":"LIPASE (PANCRELIPASE)","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lipase","Lipase (pancrelipase)"],"crossReferences":{"DailyMed":["lipase%20(pancrelipase)"]},"count":1,"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1996 and has 1 investigational indication."}
{"id":"CHEMBL1201719","drugType":"Unknown","blackBoxWarning":false,"name":"PETROLATUM, WHITE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maroline"],"synonyms":["Petrolatum, white"],"crossReferences":{"DailyMed":["petrolatum,%20white"]},"count":2,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 2 investigational indications."}
{"id":"CHEMBL121291","canonicalSmiles":"NS(=O)(=O)c1ccc(N2CCCC2=O)c([N+](=O)[O-])c1","inchiKey":"FPCPYSKJIRSWIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL121291","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24786794"],"drugbank":["DB04394"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232147","canonicalSmiles":"Nc1nc(N)c2c(OCC3CCN(Cc4cccc(Cl)c4Cl)CC3)cccc2n1","inchiKey":"XVLUVRFYGVJKGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232147","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234032","canonicalSmiles":"c1ccc2c(-c3ccncc3)n[nH]c2c1","inchiKey":"MSRXUUDVRNWSTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234032","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08113"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234956","canonicalSmiles":"O=C(O)C[C@H](OC(=O)/C=C/c1ccc(O)cc1)[C@@H](OC(=O)/C=C/c1ccc(O)cc1)C(=O)O","inchiKey":"VJLMRHSHSNLOGC-NOPZTHQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FR258900","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FR258900"],"crossReferences":{"drugbank":["DB08322"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236872","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)[C@H]1O","inchiKey":"OIRDTQYFTABQOQ-GAWUUDPSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236872","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50105851"],"drugbank":["DB03528"],"chEBI":["46515"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255871","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C(=O)[C@@H](O)CC2(C)C)C(C)(C)C[C@H](O)C1=O","inchiKey":"MQZIGYBFDRPAKN-UWFIBFSHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASTAXANTHIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E161j"],"crossReferences":{"drugbank":["DB06543"],"chEBI":["40968"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1277001","canonicalSmiles":"CC(C)S(=O)(=O)NC[C@H](C)c1ccc(-c2ccc(CCNS(C)(=O)=O)cc2)cc1","inchiKey":"ULRDYYKSPCRXAJ-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIBAMPATOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY 451395","LY-451395","LY451395","Mibampator"],"crossReferences":{"drugbank":["DB12717"]},"count":1,"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1356989","canonicalSmiles":"C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1.O=C([O-])[C@@H](O)[C@@H](O)C(=O)O.O=C([O-])[C@@H](O)[C@@H](O)C(=O)O","inchiKey":"HSMKTIKKPMTUQH-RYOVOSQWSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1356989","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1271","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112072","11112925","144204285"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1368","canonicalSmiles":"O=P([O-])(O)O.[Na+]","inchiKey":"AJPJDKMHJJGVTQ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHOSPHATE, MONOBASIC","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ionosol B","Ionosol Mb","Ionosol T"],"synonyms":["E-339(I)","E339","INS NO.339(I)","INS-339(I)","Sodium Phosphate, Monobasic","Sodium phosphate monobasic","Sodium phosphate monobasic (anhydrous)","Sodium phosphate, monobasic","Sodium phosphate, monobasic anhydrous","Sodium phosphate, monobasic, anhydrous","Sodium phosphate, monobasic, monohydrate"],"crossReferences":{"DailyMed":["sodium%20phosphate,%20monobasic,%20monohydrate"],"DrugCentral":["4271","4295"],"Wikipedia":["Monosodium_phosphate"],"drugbank":["DB09449"],"chEBI":["37585"]},"count":1,"approvedIndications":["EFO_0003103"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and is indicated for urinary tract infection."}
{"id":"CHEMBL13766","canonicalSmiles":"COc1ccccc1O","inchiKey":"LHGVFZTZFXWLCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUAIACOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 2532","Guaiacol","NSC-3815"],"crossReferences":{"PubChem":["144204582","144208334","144210188","144213965","17388828","17389094","17389539","49825822"],"Wikipedia":["Guaiacol"],"drugbank":["DB11359"],"chEBI":["28591"]},"childChemblIds":["CHEMBL224145"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1376974","canonicalSmiles":"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1.O","inchiKey":"FPJYMUQSRFJSEW-ZOWNYOTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1376974","maximumClinicalTrialPhase":0,"parentId":"CHEMBL34259","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49681549"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL13852","canonicalSmiles":"c1ccc(C2CC2)c(OCC2=NCCN2)c1","inchiKey":"YAORIDZYZDUZCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIRAZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cirazoline"],"crossReferences":{"PubChem":["104171120","11110893","11113761","124879511","124879513","144203646","170466314","26751944","26751945","50104620","50104621","90341611"],"Wikipedia":["Cirazoline"],"drugbank":["DB09202"]},"childChemblIds":["CHEMBL1255646"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1408862","canonicalSmiles":"O=[N+]([O-])C(Br)(CO)CO","inchiKey":"LVDKZNITIUWNER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRONOPOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bronopol"],"crossReferences":{"PubChem":["144205632","144210446","225144251","26757474"],"drugbank":["DB13960"],"chEBI":["31306"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1413","canonicalSmiles":"Cc1cc(C2CCCCC2)n(O)c(=O)c1","inchiKey":"SCKYRAXSEDYPSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CICLOPIROX","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ciclopirox","Loprox","Penlac"],"synonyms":["Ciclopirox","HOE 296B","HOE-296B"],"crossReferences":{"DailyMed":["ciclopirox"],"Wikipedia":["Ciclopirox"],"drugbank":["DB01188"],"chEBI":["453011"]},"childChemblIds":["CHEMBL242580"],"count":2,"approvedIndications":["EFO_1000764"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for seborrheic dermatitis and has 1 investigational indication."}
{"id":"CHEMBL14145","canonicalSmiles":"c1ccc(-c2c[nH]cn2)cc1","inchiKey":"XHLKOHSAWQPOFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Phenylimidazole","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Phenylimidazole"],"crossReferences":{"drugbank":["DB03254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL141889","canonicalSmiles":"Cc1cnc(NCC(F)(F)c2ccccn2)c(=O)n1CC(=O)NCc1ncccc1F","inchiKey":"JXHWVKOKYDAROD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL141889","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07548"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14192","canonicalSmiles":"c1ccc(Cn2ccnc2)cc1","inchiKey":"KKKDZZRICRFGSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYLIMIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzylimidazole"],"crossReferences":{"PubChem":["855733"],"drugbank":["DB04581"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1430","canonicalSmiles":"CC(C)(S)[C@@H](N)C(=O)O","inchiKey":"VVNCNSJFMMFHPL-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENICILLAMINE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cuprimine","D Mercaptovaline","D Penicillamine","Depen","Distamine","Trolovol"],"synonyms":["Dimethylcysteine","NSC-81549","Penicillamine"],"crossReferences":{"DailyMed":["penicillamine"],"PubChem":["144204450","29215023"],"TG-GATEs":["99"],"Wikipedia":["Penicillamine"],"drugbank":["DB00859"],"chEBI":["7959"]},"childChemblIds":["CHEMBL1469737"],"count":5,"approvedIndications":["EFO_0000685","Orphanet_214","Orphanet_905","EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 4 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1491","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl","inchiKey":"HTIQEAQVCYTUBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMLODIPINE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Astudal 5","Istin","Norvas","Norvasc"],"synonyms":["Amlodipine","CKD-330 COMPONENT AMLODIPINE","HGP-0904","HGP0904"],"crossReferences":{"DailyMed":["amlodipine%20benzoate","amlodipine%20besylate"],"PubChem":["124893198","225144262","29217715","50111725"],"Wikipedia":["Amlodipine"],"drugbank":["DB00381"],"chEBI":["2668"]},"childChemblIds":["CHEMBL1200402","CHEMBL4594262","CHEMBL1200984"],"count":27,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003086","EFO_0003777","EFO_0000278","EFO_0000275","EFO_0003095","EFO_0004234","EFO_0000401","MONDO_0007254","EFO_1000013","EFO_0000373","EFO_0003774","EFO_0000538","EFO_1001145","EFO_0003913","EFO_0003914","MONDO_0002050","EFO_1001375","EFO_0003144","EFO_0000712","EFO_0003884","EFO_1001996","EFO_1002032","EFO_0004285","EFO_0000400","MONDO_0000477","HP_0002140","HP_0003124","HP_0000093","EFO_0001645","EFO_0000319","EFO_0004911","EFO_0000537","EFO_0000195","HP_0012664","Orphanet_79292","EFO_0000764","EFO_0001421","EFO_0000612","EFO_0001360","Orphanet_231214","EFO_0000668","MONDO_0001422"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for cardiovascular disease and has 26 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1566","canonicalSmiles":"C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"XUFXOAAUWZOOIT-SXARVLRPSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ACARBOSE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acarbose","Glucobay","Precose"],"synonyms":["Acarbose","BAY G 5421","BAY-G-5421"],"crossReferences":{"DailyMed":["acarbose"],"PubChem":["144205150","170464784"],"TG-GATEs":["116"],"Wikipedia":["Acarbose"]},"count":11,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000257335","ENSG00000243480"],"count":2},"linkedDiseases":{"rows":["HP_0003124","EFO_0003095","EFO_0001645","EFO_0005252","EFO_0001073","EFO_0000537","EFO_0003914","GO_0007568","EFO_0000195","EFO_0004220","EFO_0004593","EFO_0000589","EFO_0001360","EFO_0000400","EFO_0007318"],"count":15},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 9 investigational indications."}
{"id":"CHEMBL1609","canonicalSmiles":"O=C(O)C(O)c1ccccc1","inchiKey":"IWYDHOAUDWTVEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANDELIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mandelic Acid","Mandelic acid"],"crossReferences":{"PubChem":["26513818","29217780","29217781","29218027","56422214"],"Wikipedia":["Mandelic_acid"],"drugbank":["DB13218"],"chEBI":["35825"]},"childChemblIds":["CHEMBL1600303","CHEMBL3248126"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL1623992","canonicalSmiles":"CCN1CCCC(OC(=O)C(c2ccccc2)c2ccccc2)C1","inchiKey":"KTHVBAZBLKXIHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERIDOLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Piperidolate"],"crossReferences":{"drugbank":["DB13351"]},"childChemblIds":["CHEMBL1511957"],"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1628243","canonicalSmiles":"CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.Cl","inchiKey":"MKMAMQPDRUXVSS-DYWKTHLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVORPHANOL HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL592","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levorphanol HCl"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1652621","canonicalSmiles":"Cc1c(CN(C)C(=O)/C=C/c2cnc3c(c2)CCC(=O)N3)oc2ccccc12","inchiKey":"QXTWSUQCXCWEHF-JXMROGBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFN-1252","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AFN-1252","API 1252","API-1252","Afn-1252","DEBIO-1452","DEBIO1452"],"crossReferences":{"drugbank":["DB12658"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL166444","canonicalSmiles":"C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C","inchiKey":"CCCIJQPRIXGQOE-XWSJACJDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METRIBOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyltrienolone","Metribolone","R 1881","R-1881"],"crossReferences":{"Wikipedia":["Metribolone"],"drugbank":["DB02998"],"chEBI":["379896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697831","canonicalSmiles":"CN(C)C(=O)CCCOC(=O)C(C)(C)Oc1ccc(Cl)cc1","inchiKey":"CXQGFLBVUNUQIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFIBRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clofibride"],"crossReferences":{"drugbank":["DB13849"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1710","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl","inchiKey":"RIULCFSTKRDHBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLUOPERAZINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL422","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stelazine","Trifluoperazine HCl"],"synonyms":[],"crossReferences":{"PubChem":["26719647","301136","50125616","50125617","56424129","855552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1711","canonicalSmiles":"CC(C)NCC(O)c1ccc(O)c(O)c1.Cl","inchiKey":"IROWCYIEJAOFOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROTERENOL HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL434","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerolone","Imuprel","Isoprenaline","Isoproterenol hydrochloride","Isuprel","Norisodrine","Norisodrine aerotrol","Oriconazole","Vapo-iso"],"synonyms":["Isopropylarterenol hydrochloride","Isoproterenol HCl","Isoproterenol hydrochloride","L-isoprenaline hydrochloride","Medihaler-Iso"],"crossReferences":{"DailyMed":["isoproterenol%20hydrochloride"],"PubChem":["144208470","144210628","17388957","26747558","26747559","26752241","50085961","50106483","50106527","50106528","56320927","56320928"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1717","canonicalSmiles":"Cl.Clc1ccccc1CN1CCc2sccc2C1","inchiKey":"MTKNGOHFNXIVOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TICLOPIDINE HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL833","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ticlid","Ticlopidine hydrochloride","Tiklid"],"synonyms":["4-C-32","53-32C","Ticlopidine hydrochloride"],"crossReferences":{"DailyMed":["ticlopidine%20hydrochloride"],"PubChem":["865815"],"chEBI":["9589"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1730","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1","inchiKey":"GPRBEKHLDVQUJE-QSWIMTSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTAXIME","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefotaxime"],"crossReferences":{"DailyMed":["cefotaxime%20sodium"],"PubChem":["26753348","50105699","90340932"],"drugbank":["DB00493"],"chEBI":["204928"]},"childChemblIds":["CHEMBL1010"],"count":5,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for bacterial disease and has 4 investigational indications."}
{"id":"CHEMBL1733","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O","inchiKey":"FLSLEGPOVLMJMN-YSSFQJQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINAPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-928","Quinaprilat"],"crossReferences":{"Wikipedia":["Quinaprilat"],"drugbank":["DB14217"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1740659","canonicalSmiles":"C/C(=C(/CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N","inchiKey":"JTLXCMOFVBXEKD-FOWTUZBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FURSULTIAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Judolor"],"synonyms":["Fursultiamine","Fursultiamine hydrochloride","TTFD"],"crossReferences":{"PubChem":["144206542"],"drugbank":["DB08966"]},"childChemblIds":["CHEMBL1705673"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1742408","canonicalSmiles":"c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2","inchiKey":"MEEQBDCQPIZMLY-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSEMOZOTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MN-305","Mkc-242","Osemozotan"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1743062","drugType":"Antibody","blackBoxWarning":false,"name":"RAMUCIRUMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyramza"],"synonyms":["1121B","IMC-1121B","LY3009806","Ramucirumab"],"crossReferences":{"DailyMed":["ramucirumab"],"DrugCentral":["4917"]},"count":37,"approvedIndications":["EFO_0000616","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_1000657","EFO_1001469","MONDO_0021063","EFO_0000708","EFO_0005952","EFO_0000228","EFO_1001951","MONDO_0001056","EFO_0000178","EFO_1000044","EFO_0000588","EFO_0000389","EFO_0000182","MONDO_0005411","EFO_0008528","EFO_1000532","EFO_0000326","EFO_0000616","EFO_0003897","EFO_0002618","EFO_0005922","EFO_0002916","EFO_0000503","MONDO_0007576","EFO_0004243","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001961","EFO_1000576","EFO_1000581","MONDO_0003219","EFO_0006544","EFO_1000895","MONDO_0024880","EFO_0000519","EFO_0001376","EFO_0000181"],"count":42},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 34 investigational indications."}
{"id":"CHEMBL180101","canonicalSmiles":"CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1","inchiKey":"CBQGYUDMJHNJBX-OALUTQOASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESREBOXETINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S,S)-Reboxetine","Esreboxetine","REBOXETINE"],"crossReferences":{"PubChem":["11114256"],"drugbank":["DB12395"]},"childChemblIds":["CHEMBL2103809"],"count":3,"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0005687","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL181","canonicalSmiles":"CC1=NS(=O)(=O)c2cc(Cl)ccc2N1","inchiKey":"GDLBFKVLRPITMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAZOXIDE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diazoxide","Eudemine","Eudimine","Hyperstat","Mutabase","Proglycem"],"synonyms":["Diazoxide","NSC-64198","NSC-76130","SCH 6783","SCH-6783","SRG 95213","SRG-95213"],"crossReferences":{"DailyMed":["diazoxide"],"PubChem":["11111111","11113823","124879964","144203683","170465328","26747146","26751995","50104671","56422090","855807"],"Wikipedia":["Diazoxide"],"drugbank":["DB01119"],"chEBI":["4495"]},"childChemblIds":["CHEMBL4297276"],"count":6,"approvedIndications":["HP_0001943","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000121361"],"count":2},"linkedDiseases":{"rows":["EFO_0004211","Orphanet_739","MONDO_0002050","MONDO_0024503","EFO_0001359","HP_0001943","MONDO_0002177","EFO_0001360","EFO_0001073","EFO_0000537"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for hypoglycemia and hypertension and has 4 investigational indications."}
{"id":"CHEMBL184023","canonicalSmiles":"CCCC/C(C)=C/C=C(\\C)C(=O)c1c(O)cc(CCC/C=C/NC(=O)OC)oc1=O","inchiKey":"QBIHIGNYQFSBGW-NOTXRLOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESMETHYL MYXOPYRONIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08226"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1928262","canonicalSmiles":"CCOc1ncc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc2c(CC)n(CCOC)nc2c(=O)[nH]1","inchiKey":"YPFZMBHKIVDSNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GISADENAFIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gisadenafil","UK-369,003","UK-369003"],"crossReferences":{"drugbank":["DB11902"]},"childChemblIds":["CHEMBL2103843"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1980297","canonicalSmiles":"Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12","inchiKey":"WPHKIQPVPYJNAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILORASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Abt-348, a-968660"],"synonyms":["A-968660","A-968660.0","ABBOTT-968660","ABT-348","Abt-348","Ilorasertib"],"crossReferences":{"PubChem":["103904272"],"drugbank":["DB11694"]},"count":2,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000037280","ENSG00000105146","ENSG00000113721","ENSG00000010810","ENSG00000134853","ENSG00000101336","ENSG00000000938","ENSG00000182866","ENSG00000178999","ENSG00000102755","ENSG00000254087","ENSG00000125508","ENSG00000136573","ENSG00000111816","ENSG00000176105","ENSG00000197122"],"count":18},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0024880","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1983268","canonicalSmiles":"CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1","inchiKey":"HAYYBYPASCDWEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENTRECTINIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rozlytrek"],"synonyms":["Entrectinib","NMS-E628","RXDX-101","Rxdx-101"],"crossReferences":{"DailyMed":["entrectinib"],"PubChem":["103905026"],"drugbank":["DB11986"]},"count":5,"approvedIndications":["EFO_0000616","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000140538","ENSG00000171094","ENSG00000148053","ENSG00000047936","ENSG00000198400"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000616","EFO_0000553","EFO_0000389","EFO_0000326","MONDO_0024880","EFO_0003060","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL2041933","canonicalSmiles":"NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1","inchiKey":"IAYGCINLNONXHY-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7762","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-7762","AZD7762","Azd 7762","Azd-7762"],"crossReferences":{"PubChem":["124950686"],"drugbank":["DB12242"]},"count":2,"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL206253","canonicalSmiles":"Cc1ccccc1-c1cc(N2CCN(C)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"WAXQNWCZJDTGBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETUPITANT","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Netupitant","RO 67-3189/000","RO-67-3189","RO-673189000"],"crossReferences":{"DailyMed":["netupitant"],"drugbank":["DB09048"],"chEBI":["85155"]},"count":2,"approvedIndications":["EFO_0006911"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for chemotherapy-induced nausea and vomiting and has 1 investigational indication."}
{"id":"CHEMBL2095212","canonicalSmiles":"Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1","inchiKey":"PBAPPPCECJKMCM-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRABEGRON","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betmiga","Myrbetriq"],"synonyms":["Mirabegron","YM-178","YM178"],"crossReferences":{"DailyMed":["mirabegron"],"drugbank":["DB08893"],"chEBI":["65349"]},"childChemblIds":["CHEMBL3542362"],"count":13,"approvedIndications":["HP_0000020","EFO_1000781","HP_0000103"],"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0002508","EFO_0006865","EFO_0008507","HP_0002571","EFO_0001073","EFO_0003843","EFO_0000660","HP_0011277","EFO_0003885","EFO_0003896","HP_0012664","EFO_1001121","EFO_0004253","EFO_0003144","HP_0000020","EFO_0001421","EFO_1000781","EFO_1000869","HP_0000011","HP_0000103"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL2097081","drugType":"Small molecule","blackBoxWarning":true,"name":"NITROPRUSSIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nitroprusside"],"crossReferences":{"DailyMed":["sodium%20nitroprusside"],"DrugCentral":["4631"],"PubChem":["29217813"],"chEBI":["7596"]},"childChemblIds":["CHEMBL3183086","CHEMBL136478"],"count":6,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000061918","ENSG00000123201"],"count":2},"linkedDiseases":{"rows":["EFO_0005252","EFO_0000319","EFO_0001358","EFO_0000537","EFO_1000653","GO_0007568","MP_0001845","MONDO_0002050","EFO_0004517","EFO_0008585","Orphanet_230","EFO_0003144","EFO_1000645","EFO_0004272","EFO_0000612","EFO_0000692","EFO_0005251"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for hypertension and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103795","canonicalSmiles":"CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[n-]2)cc1.[K+]","inchiKey":"IHWFKDWIUSZLCJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"AZILSARTAN KAMEDOXOMIL","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2028661","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edarbi"],"synonyms":["Azilsartan kamedoxomil","TAK-491"],"crossReferences":{"DailyMed":["azilsartan%20kamedoxomil"],"chEBI":["68847"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and is indicated for hypertension. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103830","canonicalSmiles":"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC","inchiKey":"GKDRMWXFWHEQQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSTAMATINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fostamatinib","R-788","R-788 FREE ACID","R-935788","R-935788 FREE ACID","R788 FREE ACID","R935788 FREE ACID"],"crossReferences":{"DailyMed":["fostamatinib%20disodium"],"PubChem":["174006453"],"drugbank":["DB12010"]},"childChemblIds":["CHEMBL3989516"],"count":9,"approvedIndications":["MP_0001914"],"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0000685","EFO_0007160","MONDO_0044903","MONDO_0100096","EFO_0002690","EFO_0001642","MONDO_0008170","EFO_0000403","EFO_0000574","EFO_1001264","EFO_0004194"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for hemorrhage and has 8 investigational indications."}
{"id":"CHEMBL2103870","canonicalSmiles":"Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1","inchiKey":"UFSKUSARDNFIRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMACAFTOR","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lumacaftor","VRT 826809","VRT-826809","VX 809","VX-809"],"crossReferences":{"DailyMed":["lumacaftor"],"drugbank":["DB09280"]},"count":2,"approvedIndications":["Orphanet_586"],"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["EFO_0001421","Orphanet_586","HP_0001657"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for cystic fibrosis and has 1 investigational indication."}
{"id":"CHEMBL2104251","canonicalSmiles":"C=C(C#N)C(=O)OCCCC","inchiKey":"JJJFUHOGVZWXNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENBUCRILATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Histoacryl","Indermil"],"synonyms":["Enbucrilate","N-butyl cyanoacrylate"],"crossReferences":{"drugbank":["DB12358"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2104991","canonicalSmiles":"Cl.c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2","inchiKey":"PYPPENBDXAWXJC-QNTKWALQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VABICASERIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110670","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCA-136","Vabicaserin hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105275","canonicalSmiles":"CNC(C)CC1CCCCC1","inchiKey":"JCRIVQIOJSSCQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPYLHEXEDRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dristan inhaler"],"synonyms":["Propylhexedrine"],"crossReferences":{"PubChem":["144206628"],"drugbank":["DB06714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105656","canonicalSmiles":"CCO.O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c([O-])nc3ncccc32)CC1.[K+]","inchiKey":"DYXNKCSVHJFUSS-LEVQAPRMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TELCAGEPANT POTASSIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL236593","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Telcagepant potassium","Telcagepant potassium salt monoethanolate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105794","canonicalSmiles":"[Na+].[OH-]","inchiKey":"HEMHJVSKTPXQMS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM HYDROXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium hydroxide"],"crossReferences":{"DrugCentral":["4636"],"drugbank":["DB11151"],"chEBI":["32145"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105977","canonicalSmiles":"C[N+]1(CC2CC2)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.[Br-]","inchiKey":"WDURTRGFUGAJHA-GSWUYBTGSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMETROPIUM BROMIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110773","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cimetropium bromide","DA-3177"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106357","canonicalSmiles":"O=C(O)CCC(=O)c1ccc2c(c1)-c1cccc3cccc-2c13","inchiKey":"QOBAOSCOLAGPKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORANTYRONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Florantyrone"],"crossReferences":{"drugbank":["DB08975"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106441","canonicalSmiles":"CNC(=S)NCO","inchiKey":"JLMHZVYLAQPMOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOXYTIOLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Noxyflex","Noxyflex 100","Noxyflex-s","Noxyflex-s 100"],"synonyms":["Noxythiolin","Noxytiolin"],"crossReferences":{"drugbank":["DB13838"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107457","canonicalSmiles":"COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC","inchiKey":"QQQIECGTIMUVDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITOPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Itopride"],"crossReferences":{"drugbank":["DB04924"]},"childChemblIds":["CHEMBL2139257"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2107833","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"ARPBZBAWXAVDCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBASTINIB TOSYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1738757","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dp-1919.to, dcc-2036"],"synonyms":["Rebastinib tosylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108126","drugType":"Unknown","blackBoxWarning":false,"name":"PSYLLIUM HUSK","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hydrocil instant","Modane bulk","Mylanta fiber","Syllact"],"synonyms":["Plantago seed psyllium hydrophylic mucilloid","Psyllium husk","Psyllium hydrophilic mucilloid"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108163","drugType":"Unknown","blackBoxWarning":false,"name":"ULINASTATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AER-002","Ulinastatin","Urinastatin"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108248","drugType":"Antibody","blackBoxWarning":false,"name":"ANATUMOMAB MAFENATOX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Anyara"],"synonyms":["ABR-214936","Anatumomab mafenatox"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108390","drugType":"Unknown","blackBoxWarning":false,"name":"FIBRIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fibrin"],"count":23,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 23 investigational indications."}
{"id":"CHEMBL2108462","drugType":"Unknown","blackBoxWarning":false,"name":"GALASOMITE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Synsorb pk"],"synonyms":["Galasomite","SBI-0067"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108546","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGASPARGASE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oncaspar"],"synonyms":["Asparaginase compd with polyethylene glycol","Asparaginase e. coli compd with polyethylene glycol","Pegaspargase"],"crossReferences":{"DailyMed":["pegaspargase"],"DrugCentral":["5082"]},"count":13,"approvedIndications":["EFO_0000616","MONDO_0000873","EFO_0000220","MONDO_0000870"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL2108566","drugType":"Antibody","blackBoxWarning":false,"name":"NERELIMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Humicade"],"synonyms":["BAY X 1351","BAY-103356","BAY-X-1351","CDP-571","Nerelimomab","TNF MAB","TNF-MAB"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108666","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["90Y-DOTA-HLL2","S9S0Y-DOTA-HLL2","Yttrium y 90 epratuzumab tetraxetan"],"count":4,"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000096","EFO_0000403","MONDO_0018906","EFO_0000094"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108728","drugType":"Enzyme","blackBoxWarning":false,"name":"CALASPARGASE PEGOL","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asparlas"],"synonyms":["Calaspargase pegol","Calaspargase pegol-mknl","EZN-2285"],"crossReferences":{"DailyMed":["calaspargase%20pegol-mknl"]},"count":2,"approvedIndications":["MONDO_0000873","EFO_0000220"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for acute lymphoblastic leukemia and lymphoblastic lymphoma."}
{"id":"CHEMBL2108906","drugType":"Small molecule","blackBoxWarning":false,"name":"BELLADONNA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atropa belladonna","Belladonna","Belladonna extract","Belladonna total alkaloids"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109134","drugType":"Protein","blackBoxWarning":false,"name":"MOLGRAMOSTIM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Leucomax"],"synonyms":["Granulocyte-macrophage colony-stimulating factor molgramostim","Molgramostim","Molgramostim (genetical recombination)","SCH 39300","SCH-39300"],"count":5,"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109208","drugType":"Unknown","blackBoxWarning":false,"name":"MARITIME PINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maritime pine","Pinus pinaster","Pinus pinaster bark","Pinus pinaster bark extract","Pycnogenol"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109342","drugType":"Antibody","blackBoxWarning":false,"name":"HGS-1025","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HGS-1025","Hgs-1025"],"count":1,"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111047","canonicalSmiles":"CCCC(Cc1ccccc1)N1CCCC1","inchiKey":"OJCPSBCUMRIPFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROLINTANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prolintane"],"crossReferences":{"drugbank":["DB13438"]},"childChemblIds":["CHEMBL2107189"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2145077","canonicalSmiles":"COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2.Cl","inchiKey":"HLUKNZUABFFNQS-ZMBIFBSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IVABRADINE HYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL471737","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corlanor","Procoralan"],"synonyms":["AMG 998","Ivabradine","Ivabradine hydrochloride","S 16257"],"crossReferences":{"DailyMed":["ivabradine%20hydrochloride"],"PubChem":["144206355"],"chEBI":["85969"]},"count":2,"approvedIndications":["EFO_0003144","EFO_0000373"],"linkedTargets":{"rows":["ENSG00000138622"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000373"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for heart failure and congestive heart failure."}
{"id":"CHEMBL2146086","canonicalSmiles":"CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1.O=S(=O)(O)c1ccccc1","inchiKey":"ARQUTWAXTHJROR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRENOLANIB BESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105728","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["596-26","ARO-002-26","CP-868","CP-868,596-26","CP-868596-26","Crenolanib besilate","Crenolanib besylate"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2146108","canonicalSmiles":"O=C(CCn1cnc2c(=O)[nH]cnc21)Nc1ccc(C(=O)[O-])cc1.[K+]","inchiKey":"MICLTPPSCUXHJT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"LETEPRINIM POTASSIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2104345","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neotrofin"],"synonyms":["AIT-082","Leteprinim potassium","Leteprinim potassium salt"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL216371","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.O=C(O)C(F)(F)F","inchiKey":"UDTIHEAQOFADHN-RUELKSSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXORUBICIN TRIFLUOROACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL53463","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doxorubicin Trifluoroacetate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218894","canonicalSmiles":"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21.[Na+]","inchiKey":"ZGGHKIMDNBDHJB-CALJPSDSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUVASTATIN SODIUM","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2220442","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dorisin xl","Fluvastatin sodium","Lescol","Lescol xl","Luvinsta xl","Nandovar xl","Pinmactil","Stefluvin xl"],"synonyms":["Fluvastatin sodium","Fluvastatin sodium salt","XU 62-320","XU-62-320"],"crossReferences":{"DailyMed":["fluvastatin%20sodium"]},"count":2,"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0000589","HP_0003124","MONDO_0007254"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 2 investigational indications."}
{"id":"CHEMBL2272031","canonicalSmiles":"CCCCC[C@@H](O)[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C/C=C/C=C/C=C/C=C(\\C)[C@@H](O)[C@H](O)[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O","inchiKey":"AGJUUQSLGVCRQA-SWOUQTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pentamycin"],"crossReferences":{"drugbank":["DB13571"],"chEBI":["31639"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233209","canonicalSmiles":"CC(C)(N)c1ccc(-c2nc(Nc3ccc(CCN4CCOCC4)cc3)ncc2Cl)cc1","inchiKey":"CJSSYVIHFXDFFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233209","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02491"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2387408","canonicalSmiles":"CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(=O)O)CC(=O)O)c(OC)cc2[C@@H](c2ccccc2)N1","inchiKey":"CZGVOBIGEBDYTP-VSGBNLITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINERIXIBAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK2330672","Gsk2330672","Linerixibat"],"crossReferences":{"drugbank":["DB11729"]},"count":3,"linkedTargets":{"rows":["ENSG00000125255"],"count":1},"linkedDiseases":{"rows":["MONDO_0001751","MONDO_0019072","EFO_0001360"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL253629","canonicalSmiles":"NC(=O)c1[nH]c2ccc(Br)cc2c1S(=O)(=O)N1CCCC1","inchiKey":"FEPUPYVRZUWCQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253629","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08211"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257341","canonicalSmiles":"CC(C)Nc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1","inchiKey":"FQYJTHIYAQQJAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257341","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08352"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278172","canonicalSmiles":"CCOC(=O)c1ccc(N)cc1","inchiKey":"BLFLLBZGZJTVJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOCAINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aezodent","Americaine","Anthisan plus","Baby anbesol","Burneze","Children's chloraseptic","Dequacaine","Lanacane","Medilave","Nestosyl","Orajel","Tyrosolven","Tyrozets"],"synonyms":["AR-01","AR01","Benzocaine","Ethyl aminobenzoate","NSC-41531","NSC-4688"],"crossReferences":{"PubChem":["11112244","144203942","144211466","170465463","26747880","56422766"],"Wikipedia":["Benzocaine"],"drugbank":["DB01086"],"chEBI":["116735"]},"count":8,"approvedIndications":["HP_0000989","EFO_0009552"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pruritus and hemorrhoid and has 6 investigational indications."}
{"id":"CHEMBL284092","canonicalSmiles":"CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1","inchiKey":"QOIGKGMMAGJZNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEPIRONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ariza","BMY-13805","Gepirone","ORG-13011","Variza"],"crossReferences":{"Wikipedia":["Gepirone"],"drugbank":["DB12184"]},"childChemblIds":["CHEMBL1204187"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL29404","canonicalSmiles":"Cc1nc(OCCCCCN2CCCCC2)cc(-c2ccc(F)cc2)n1","inchiKey":"SZSHJTJCJOWMHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENECADIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enecadin"],"crossReferences":{"drugbank":["DB13032"]},"childChemblIds":["CHEMBL2401778"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL295830","canonicalSmiles":"NC1(C(=O)O)CCCC1","inchiKey":"NILQLFBWTXNUOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOLEUCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Amino-Cyclopentanecarboxylic Acid","1-Aminocyclopentanecarboxylic Acid","Cycloleucine","Cycloleucine1-Amino-Cyclopentanecarboxylic Acid"],"crossReferences":{"PubChem":["67889"],"Wikipedia":["Cycloleucine"],"drugbank":["DB04620"],"chEBI":["40547"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL310554","canonicalSmiles":"O=C[C@H](CC(=O)O)NC(=O)c1cncc(-c2ccc(C(=O)O)cc2)c1","inchiKey":"JNRAPROKLOUIRA-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL310554","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08251"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3181947","canonicalSmiles":"Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.O.O.O.[Na+].[Na+]","inchiKey":"PPOSVVJOVKVBPW-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3181947","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1077","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205734","170465189"],"chEBI":["59176"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183440","canonicalSmiles":"CC=CC(=O)N(CC)c1ccccc1C","inchiKey":"DNTGGZPQPQTDQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183440","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144203997","144211121","170464851","174006207"],"drugbank":["DB00265"],"chEBI":["31439"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3185877","canonicalSmiles":"Br.CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"WTGQALLALWYDJH-MOUKNHLCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185877","maximumClinicalTrialPhase":0,"parentId":"CHEMBL569713","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212336","170464830"],"chEBI":["61271"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188084","canonicalSmiles":"N#CCCC(Br)(C#N)CBr","inchiKey":"DHVLDKHFGIVEIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3188084","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212268"],"drugbank":["DB14199"],"chEBI":["62823"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL320049","canonicalSmiles":"O=C(Cc1cccs1)NCB(O)O","inchiKey":"VXAPSUDMBNWYNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL320049","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02094"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL324794","canonicalSmiles":"OC/C=C/c1ccccc1","inchiKey":"OOCCDEMITAIZTP-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINNAMIC ALCOHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(E)-Cinnam Alcohol","Cinnamic Alcohol","Cinnamyl Alcohol"],"crossReferences":{"Wikipedia":["Cinnamyl_alcohol"],"drugbank":["DB14186"],"chEBI":["33227"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL324951","canonicalSmiles":"COc1ccc(OC)c(Cc2nc3nc(F)nc(N)c3[nH]2)c1","inchiKey":"MWHAHELTVGJGFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL324951","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3250420","canonicalSmiles":"N[14c]1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"NMUSYJAQQFHJEW-PDWQNIEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250420","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1489","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3319236","canonicalSmiles":"COc1ccc(S(=O)(=O)N[C@@H](CNc2nc(C)nc(N3CCC(c4ccc5c(n4)NCCC5)CC3)c2C)C(=O)O)cc1","inchiKey":"CXHCNOMGODVIKB-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLPG-0187","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GLPG0187","Glpg-0187","Glpg0187"],"crossReferences":{"drugbank":["DB12297"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3350449","canonicalSmiles":"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.O=[14C]1O[C@H]([C@@H](O)CO)C(O)=C1O","inchiKey":"RCSUPSZIWSHAFM-DKUGQOLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3350449","maximumClinicalTrialPhase":0,"parentId":"CHEMBL139","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3414621","canonicalSmiles":"CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1","inchiKey":"NSQSAUGJQHDYNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAZEMETOSTAT","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-7438","E7438","EPZ-6438","Tazemetostat"],"crossReferences":{"DailyMed":["tazemetostat%20hydrobromide"],"drugbank":["DB12887"]},"childChemblIds":["CHEMBL4594260"],"count":9,"linkedTargets":{"rows":["ENSG00000106462"],"count":1},"linkedDiseases":{"rows":["EFO_0000588","EFO_0000096","MONDO_0017387","EFO_0000403","EFO_0008528","EFO_0000574","EFO_0000196","MONDO_0018906","EFO_0000691","EFO_0000181","MONDO_0001187"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 9 investigational indications."}
{"id":"CHEMBL3526451","canonicalSmiles":"[3H]C1C2=CC(=O)C([3H])C([3H])[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(O[14C](=O)CCCCC)C(C)=O)[C@@H]2C1[3H]","inchiKey":"DOMWKUIIPQCAJU-ZAHTZBBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526451","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1200848","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3526472","canonicalSmiles":"Cc1cc2c(F)c(Oc3n[14cH]nn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1","inchiKey":"LTEJRLHKIYCEOX-TYTWNPOGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526472","maximumClinicalTrialPhase":0,"parentId":"CHEMBL270995","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545057","canonicalSmiles":"CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O","inchiKey":"HPMZBILYSWLILX-UMDUKNJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLDIGITOXIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acylanid"],"synonyms":["Acetyldigitoxin"],"crossReferences":{"drugbank":["DB00511"],"chEBI":["53773"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000163399","ENSG00000018625","ENSG00000105409","ENSG00000132681"],"count":4},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for cardiovascular disease."}
{"id":"CHEMBL3545068","canonicalSmiles":"COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21.Cl.Cl","inchiKey":"STGQPVQAAFJJFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COPANLISIB HYDROCHLORIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3218576","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aliqopa"],"synonyms":["BAY 80-6946 DIHYDROCHLORIDE","BAY 84-1236","BAY-80-6946 DIHYDROCHLORIDE","BAY-84-1236","Copanlisib dihydrochloride","Copanlisib hydrochloride"],"crossReferences":{"DailyMed":["copanlisib%20dihydrochloride"]},"count":4,"approvedIndications":["EFO_0000096"],"linkedTargets":{"rows":["ENSG00000171608","ENSG00000121879"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000304","EFO_0000096","EFO_0000095","EFO_0000403","EFO_0000305"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for neoplasm of mature b-cells and has 3 investigational indications."}
{"id":"CHEMBL3545089","drugType":"Small molecule","blackBoxWarning":false,"name":"IMD-0354","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imd-0354"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545138","drugType":"Small molecule","blackBoxWarning":false,"name":"PRT-2607","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-057","P505-15","PRT-062607","Prt-2607"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545174","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2881078","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2881078"],"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["HP_0004326"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545297","drugType":"Small molecule","blackBoxWarning":false,"name":"PEXMETINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARRY-614","Arry-614","Pexmetinib"],"count":1,"linkedTargets":{"rows":["ENSG00000112062","ENSG00000120156"],"count":2},"linkedDiseases":{"rows":["EFO_0000198"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545358","drugType":"Small molecule","blackBoxWarning":false,"name":"4SC-203","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4sc 203","4sc-203"],"count":1,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000122025"],"count":4},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545367","canonicalSmiles":"Cc1ncc(OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1","inchiKey":"MUGXRYIUWFITCP-PGRDOPGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEMBOREXANT","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dayvigo"],"synonyms":["E-2006","E2006","Lemborexant"],"crossReferences":{"DailyMed":["lemborexant"],"drugbank":["DB11951"]},"count":5,"approvedIndications":["EFO_0004698"],"linkedTargets":{"rows":["ENSG00000137252","ENSG00000121764"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001421","MONDO_0024361","EFO_0003918","EFO_0004698"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for insomnia and has 4 investigational indications."}
{"id":"CHEMBL363614","canonicalSmiles":"c1ccc2occc2c1","inchiKey":"IANQTJSKSUMEQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOFURAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzofuran"],"crossReferences":{"PubChem":["144214015","17390023","26752901","26752902","85272551"],"Wikipedia":["Benzofuran"],"drugbank":["DB04179"],"chEBI":["35260"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707286","canonicalSmiles":"COc1ccc(-c2cc(=O)c3c(OCCO)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O","inchiKey":"XYFLWVOTXWXNAM-WTNNCJBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HIDROSMIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hidrosmin"],"crossReferences":{"drugbank":["DB13490"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3765217","canonicalSmiles":"CCn1cc(C(=O)[O-])c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21.[K+]","inchiKey":"ZRKHXWCSHDBBQU-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3765217","maximumClinicalTrialPhase":0,"parentId":"CHEMBL561","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833317","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC PYROPHOSPHATE CITRATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Triferic","Triferic avnu"],"synonyms":["Ferric pyrophosphate citrate","H-61","H61","SFP"],"crossReferences":{"DailyMed":["ferric%20pyrophosphate%20citrate"],"DrugCentral":["5122"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 investigational indications."}
{"id":"CHEMBL3833340","canonicalSmiles":"C[C@H]1[C@H](NC(=O)/C(=N\\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O.NCCCC[C@H](N)C(=O)O","inchiKey":"KPPBAEVZLDHCOK-JHBYREIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZTREONAM LYSINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL158","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cayston"],"synonyms":["Aztreonam l-lysine salt","Aztreonam lysine","CORUS-1020","CORUS1020","Corus 1020"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL38700","canonicalSmiles":"Nc1nc(=O)n([C@@H]2C=C[C@H](CO)O2)cc1F","inchiKey":"HSBKFSPNDWWPSL-VDTYLAMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELVUCITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACH-126,443","ACH-126443","Elvucitabine"],"crossReferences":{"Wikipedia":["Elvucitabine"],"drugbank":["DB06236"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989750","canonicalSmiles":"N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.O=S(=O)(O)O","inchiKey":"CVCQAQVBOPNTFI-AAONGDSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCOSAMINE SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL493287","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dolenio","Glusartel"],"synonyms":["Glucosamine sulf ","Glucosamine sulfate","Glucosamine sulfate salt"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989858","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].O.O.O.O.[Mg+2]","inchiKey":"XKPKPGCRSHFTKM-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM ACETATE TETRAHYDRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200691","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Magnesium acetate tetrahydrate"],"crossReferences":{"drugbank":["DB09409"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3989943","canonicalSmiles":"CS(=O)(=O)CCC#N","inchiKey":"LQFRYKBDZNPJSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPANSUTRILE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dapansutrile","OLT-1177","OLT1177"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989962","canonicalSmiles":"NC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1.O.O","inchiKey":"DUORKVZYABUEHW-AHJYMZSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMETREXED TROMETHAMINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL225072","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pemetrexed tromethamine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL408","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2","inchiKey":"GXPHKUHSUJUWKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROGLITAZONE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Hepatotoxicity"],"year":1997},"tradeNames":["Prelay","Rezulin","Romozin"],"synonyms":["CI-991","CS-045","GR-92132X","GR92132X","Rezulin","Troglitazone"],"crossReferences":{"PubChem":["137275811","144205672","144210788","170465091","174007238","26755242","26755243","26757864","29216382"],"Wikipedia":["Troglitazone"],"drugbank":["DB00197"],"chEBI":["9753"]},"count":2,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0000400","EFO_0000691"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for diabetes mellitus and has 1 investigational indication. It was withdrawn in United States  in 1997 due to Hepatotoxicity."}
{"id":"CHEMBL4297189","name":"CHEMBL4297189","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14917"]}}
{"id":"CHEMBL4297243","drugType":"Cell","blackBoxWarning":false,"name":"EMIPLACEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emiplacel","PLX-PAD","PLXPAD"],"count":6,"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297352","canonicalSmiles":"C[C@]1(CS(=O)(=O)N2CCC(Oc3ccc(Cl)cn3)CC2)NC(=O)NC1=O","inchiKey":"SFJFBTPHDHUUPU-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-1236","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD1236","Azd 1236","Azd-1236","Azd1236"],"crossReferences":{"drugbank":["DB11961"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297437","canonicalSmiles":"O=C1N=C2C=CC=CN2C12Cc1ccccc1C2","inchiKey":"QZWYXEBIQWJXAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ST-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ST101","St-101","St101","ZSET-1446"],"crossReferences":{"drugbank":["DB12621"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297544","canonicalSmiles":"C=C(C#N)C(=O)OC(C)CCCCCC","inchiKey":"CQVWXNBVRLKXPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-OCTYL CYANOACRYLATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-octyl cyanoacrylate","Dermabond"],"crossReferences":{"drugbank":["DB12040"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297584","canonicalSmiles":"CC[C@H](Nc1ncnc2[nH]cnc12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1","inchiKey":"HDXDQPRPFRKGKZ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tenalisib"],"crossReferences":{"drugbank":["DB15295"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297611","canonicalSmiles":"CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1","inchiKey":"YFHRCLAKZBDRHN-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VENGLUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GENZ-682452","GZ-402671","GZ/SAR402671","GZ402671","Genz-682452","Genz-682452-AA","Gz402671","SAR-402671","SAR402671","Venglustat"],"crossReferences":{"drugbank":["DB14966"]},"childChemblIds":["CHEMBL4594270"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297638","canonicalSmiles":"Cn1cc(-c2ccc(S(=O)(=O)[C@@H]3C[C@@H](C(=O)NC4(C#N)CC4)N(C(=O)C4(C(F)(F)F)CC4)C3)c(C(F)(F)F)c2)cn1","inchiKey":"KXAAIORSMACJSI-AEFFLSMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PETESICATIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Petesicatib","RG-7625","RG7625","RO-5459072","RO5459072","Rg7625","Ro5459072"],"crossReferences":{"drugbank":["DB15297"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297886","drugType":"Protein","blackBoxWarning":false,"name":"ASUNERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APG-101","APG101","Apg101","Asunercept","CAN-008"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297912","drugType":"Unknown","blackBoxWarning":false,"name":"BIFIDOBACTERIUM SPP.","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bifidobacteria","Bifidobacterium nos","Bifidobacterium spp."],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297928","drugType":"Unknown","blackBoxWarning":false,"name":"NOMACOPAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coversin","Nomacopan","REV-576","REV-675","REV675","rEV576"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297963","drugType":"Unknown","blackBoxWarning":false,"name":"GP-100 ANTIGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gp-100 antigen","Gp100 antigen"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298098","drugType":"Unknown","blackBoxWarning":false,"name":"SAR-408701","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-408701","SAR408701","Sar 408701","Sar-408701","Sar408701"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298109","drugType":"Unknown","blackBoxWarning":false,"name":"IRL-1620","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irl-1620","SPI-1620","Sovateltide","Spi 1620","Spi-1620"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL429910","canonicalSmiles":"CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1","inchiKey":"JVHXJTBJCFBINQ-ADAARDCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPAGLIFLOZIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Forxiga"],"synonyms":["BMS-512148","BMS-512148-05","Dapagliflozin"],"crossReferences":{"DailyMed":["dapagliflozin"],"Wikipedia":["Dapagliflozin"],"drugbank":["DB06292"],"chEBI":["85078"]},"childChemblIds":["CHEMBL3125457","CHEMBL3125455","CHEMBL3125318","CHEMBL3125316","CHEMBL3125317","CHEMBL2103802","CHEMBL3125456","CHEMBL3125458"],"count":11,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0009104","HP_0000093","EFO_0000249","EFO_0001645","EFO_0000401","EFO_1001249","EFO_0004236","HP_0001824","EFO_0004194","EFO_0001073","EFO_0000660","EFO_0000537","EFO_0000195","GO_0007568","HP_0012664","MONDO_0100096","EFO_1001121","EFO_0003144","EFO_0001359","EFO_0003884","HP_0003074","EFO_1001207","EFO_0001360","EFO_0000400","EFO_0003940","EFO_1000899"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for diabetes mellitus and has 10 investigational indications."}
{"id":"CHEMBL433921","canonicalSmiles":"COc1cccc(N2C(CN3CCOCC3)=Cc3cc(S(N)(=O)=O)sc3S2(=O)=O)c1","inchiKey":"XSUAVPPTKHUTDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AL-6629","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-6629"],"crossReferences":{"drugbank":["DB03598"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL440294","canonicalSmiles":"NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1","inchiKey":"AXKPFOAXAHJUAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPAMPERONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Floropipamide","Pipamperone","Pipamperone hydrochloride","Pipaneperone","R 3345","R-3345"],"crossReferences":{"PubChem":["29217622","50111712"],"Wikipedia":["Pipamperone"],"drugbank":["DB09286"],"chEBI":["78549"]},"childChemblIds":["CHEMBL2361301"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL441687","canonicalSmiles":"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C","inchiKey":"LPLVUJXQOOQHMX-QWBHMCJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCYRRHIZIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E958","Glycyrrhetinic acid","Glycyrrhizic Acid","Glycyrrhizic acid","Glycyrrhizin","Glycyrrhizinic acid","NSC-167409","NSC-234419"],"crossReferences":{"PubChem":["144205073","144206976","144213802","26755251"],"drugbank":["DB13751"],"chEBI":["15939"]},"childChemblIds":["CHEMBL3561931","CHEMBL4536688","CHEMBL1923952"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL452289","canonicalSmiles":"NC(=O)c1cccc(-c2ccc([C@H](N)Cc3cc(F)ccc3F)cc2)c1","inchiKey":"JYKFWUXBFJJDTP-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL452289","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07181"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL456163","canonicalSmiles":"CC(=O)Nc1c[nH]nc1C(=O)Nc1ccc(F)cc1","inchiKey":"CWQKPKYIMQTGJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL456163","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL457748","canonicalSmiles":"Cc1cc(OC[P@@]2(=O)OCC[C@@H](c3cccc(Cl)c3)O2)cc(C)c1Cc1ccc(O)c(C(C)C)c1","inchiKey":"LGGPZDRLTDGYSQ-JADSYQMUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MB07811","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MB07811","Mb07811","VK2809"],"crossReferences":{"drugbank":["DB15137"]},"count":3,"linkedTargets":{"rows":["ENSG00000151090"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_1001249","EFO_0003774"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL458975","canonicalSmiles":"O=C([C@@H]1CC(F)(F)CN1C(=O)CCN1C(=O)c2ccccc2C1=O)N1CCCC1","inchiKey":"ZSXNPAWXICXNGZ-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL458975","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08739"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594339","drugType":"Antibody","blackBoxWarning":false,"name":"OMODENBAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["514G3","514g3","Omodenbamab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594516","drugType":"Antibody","blackBoxWarning":false,"name":"REVDOFILIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-368","ABBV368","Abbv-368","PR-1628103","PR1628103","Revdofilimab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594519","drugType":"Unknown","blackBoxWarning":false,"name":"ADG-106","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADG-106","ADG106","Adg-106","Adg106"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594560","drugType":"Gene","blackBoxWarning":false,"name":"ROCAKINOGENE SIFUPLASMID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INO-9012","Ino-9012","Rocakinogene sifuplasmid"],"count":4,"description":"Gene drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL467773","canonicalSmiles":"CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"HOVAGTYPODGVJG-PZRMXXKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL467773","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02100"],"chEBI":["55507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL471524","canonicalSmiles":"Nc1ncnc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)[nH]nc12","inchiKey":"KBHMEHLJSZMEMI-KSYZLYKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02281"],"chEBI":["42452"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL488093","canonicalSmiles":"Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O","inchiKey":"SIXLXDIJGIWWFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITINOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrithioxine","Pyrithioxine hydrochloride","Pyritinol"],"crossReferences":{"PubChem":["29217898"],"Wikipedia":["Pyritinol"],"drugbank":["DB13084"]},"childChemblIds":["CHEMBL2355482"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL49429","canonicalSmiles":"Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1","inchiKey":"PPHTXRNHTVLQED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIXIVAPTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lixar"],"synonyms":["CRTX 080","CRTX-080","Lixivaptan","VPA 985","VPA-985","Vpa-985","WAY-VPA-985"],"crossReferences":{"Wikipedia":["Lixivaptan"],"drugbank":["DB06666"]},"childChemblIds":["CHEMBL3526685"],"count":4,"linkedTargets":{"rows":["ENSG00000126895"],"count":1},"linkedDiseases":{"rows":["EFO_0008620","HP_0002902","EFO_0000373","EFO_1001496"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL501122","canonicalSmiles":"CCO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1","inchiKey":"ZCCUWMICIWSJIX-NQJJCJBVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTAROLINE FOSAMIL","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ceftaroline fosamil","PPI-0903","TAK 599","TAK-599"],"crossReferences":{"DailyMed":["ceftaroline%20fosamil"],"Wikipedia":["Ceftaroline_fosamil"],"drugbank":["DB06590"],"chEBI":["70718"]},"childChemblIds":["CHEMBL3544973"],"count":9,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for bacterial disease and has 8 investigational indications."}
{"id":"CHEMBL531048","canonicalSmiles":"O=C1C(=O)c2ncccc2-c2cccnc21","inchiKey":"VLPADTBFADIFKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHANQUONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-11925","GNF-Pf-1759","Phanchinone","Phanquinone","Phanquone"],"crossReferences":{"PubChem":["144205320","29216050"],"Wikipedia":["Phanquinone"],"drugbank":["DB13469"],"chEBI":["59141"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL541758","canonicalSmiles":"Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCOCC4)c3Cl)c2n1.[Cl-]","inchiKey":"ZNHJDJYKDVGQSH-JMAPEOGHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FASITIBANT CHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL218427","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasitibant chloride","Men16132"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL542496","canonicalSmiles":"CC(=O)Nc1nnc(S(N)(=O)=O)s1.Cl","inchiKey":"PHPRKHXGABBPQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL542496","maximumClinicalTrialPhase":0,"parentId":"CHEMBL20","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL560739","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC","inchiKey":"DCSUBABJRXZOMT-IRLDBZIGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL560739","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00604"],"chEBI":["3720"]},"childChemblIds":["CHEMBL1546244"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL56904","canonicalSmiles":"CN1CCN(Cc2ccc(C(=O)Nc3cccc(Nc4nccc(-c5cccnc5)n4)c3)cc2)CC1","inchiKey":"JHMBUEWQJDGKGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Demethyl-imatinib","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demethyl-imatinib"],"crossReferences":{"drugbank":["DB04739"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62381","canonicalSmiles":"CCCC(=O)[O-].[Na+]","inchiKey":"MFBOGIVSZKQAPD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BUTYRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-174280","Sodium butyrate"],"crossReferences":{"PubChem":["144206103","563607"],"Wikipedia":["Sodium_butyrate"],"chEBI":["64103"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL64130","canonicalSmiles":"CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O","inchiKey":"DPHUWDIXHNQOSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPABUCASIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Acetylfuranonaphthoquinone","BBI-608","BBI608","Napabucasin"],"crossReferences":{"drugbank":["DB12155"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL71927","canonicalSmiles":"CCN1c2cc([N+](=O)[O-])ccc2N(C)C(=O)c2cccnc21","inchiKey":"YCFJZPGDTZVVSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL71927","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08665"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL779","canonicalSmiles":"CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O","inchiKey":"WOXKDUGGOYFFRN-IIBYNOLFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TADALAFIL","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adcirca","Cialis"],"synonyms":["IC-351","IC351","LY-450190","LY450190","Tadalafil"],"crossReferences":{"DailyMed":["tadalafil"],"PubChem":["144206195","170464819","26719828","49666420"],"Wikipedia":["Tadalafil"],"drugbank":["DB00820"],"chEBI":["71940"]},"count":30,"approvedIndications":["EFO_0004234","HP_0000802","EFO_0000284"],"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","Orphanet_98895","EFO_0004718","EFO_0004234","HP_0000802","EFO_0000284","EFO_0000373","EFO_0000266","EFO_1000948","Orphanet_98473","EFO_1001145","EFO_1000044","EFO_0003099","EFO_0004253","EFO_0000712","EFO_0004244","EFO_1002032","EFO_0000717","EFO_0000616","HP_0001952","MONDO_0005149","MONDO_0000153","EFO_0009200","HP_0200023","EFO_0001073","EFO_1002002","EFO_0000311","EFO_0000537","Orphanet_98896","EFO_0002614","EFO_0004284","EFO_0001378","EFO_0001360","EFO_0000181","HP_0030680"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 27 investigational indications."}
{"id":"CHEMBL78455","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"SAFPHFWYRLLBFO-NSOVKSMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL78455","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01678"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL815","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O","inchiKey":"PXGPLTODNUVGFL-YNNPMVKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINOPROST","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dinoprost","U-14,583","U-14583"],"crossReferences":{"PubChem":["144205330","29216066"],"Wikipedia":["Prostaglandin_F2alpha"],"drugbank":["DB12789"],"chEBI":["15553"]},"childChemblIds":["CHEMBL1200896"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL820","canonicalSmiles":"CS(=O)(=O)OCCCCOS(C)(=O)=O","inchiKey":"COVZYZSDYWQREU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUSULFAN","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Busilvex","Busulfan","Busulfex","Myleran"],"synonyms":["Busulfan","Myelosan","NCI-C01592","NSC-750","Sulphabutin"],"crossReferences":{"DailyMed":["busulfan"],"PubChem":["144204589","144209046","144210637","170465232","17388889","17389813","174007363","26747279","26752840","49648470","67633"],"Wikipedia":["Busulfan"],"drugbank":["DB01008"],"chEBI":["28901"]},"count":86,"approvedIndications":["EFO_0000565","EFO_0000616","EFO_0000339","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and has 4 approved and 82 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL866","canonicalSmiles":"COc1c(C)c2c(c(O)c1C/C=C(\\C)CCC(=O)O)C(=O)OC2","inchiKey":"HPNSFSBZBAHARI-RUDMXATFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MYCOPHENOLIC ACID","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mycophenolic acid","Myfortic"],"synonyms":["68618","Mycophenolate mofetil impurity, mycophenolic acid-","Mycophenolic acid","NSC-129185","RS-61443 [AS MOFETIL]"],"crossReferences":{"DailyMed":["mycophenolic%20acid"],"PubChem":["11112696","11112697","11114111","124882524","124882525","124882528","124882529","124882530","144204161","170465182","26747168","26752207","26752208","420202","47193743","50104875","85148364"],"Wikipedia":["Mycophenolic_acid"],"drugbank":["DB01024"],"chEBI":["168396"]},"childChemblIds":["CHEMBL2106643"],"count":12,"approvedIndications":["EFO_0000540"],"linkedTargets":{"rows":["ENSG00000106348","ENSG00000178035"],"count":2},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0003086","EFO_0005761","EFO_0002687","EFO_1001020","EFO_0000222","EFO_0000319","EFO_0000540","EFO_0004599","EFO_1002048","EFO_0000384","HP_0000083","EFO_0001422","EFO_1000986","EFO_0003765","EFO_0002690","HP_0001871","EFO_0000544","EFO_0001359","EFO_0000182","EFO_0003884","EFO_0004255","EFO_0005140","EFO_0000717","EFO_0000699","EFO_0001062","EFO_0009878"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for immune system disease and has 11 investigational indications. This drug has a black box warning from the FDA."}
